$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000155335024000141 Filed on September 30, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue			$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$6.374K		$23.42K
YoY Change	-23.2%		-71.71%
% of Gross Profit
Depreciation & Amortization	$285.00		$1.582K
YoY Change	-38.18%		-3.83%
% of Gross Profit
Operating Expenses	$966.1K		$2.071M
YoY Change	43.12%		-34.4%
Operating Profit	-$966.1K		-$2.071M
YoY Change	43.12%		-34.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$205.6K		-$9.620M
YoY Change	191.46%		-29657.17%
Pretax Income
YoY Change
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.172M		-$11.69M
YoY Change	57.15%		266.59%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02		-$0.22
Diluted Earnings Per Share	-$0.02		-$0.22
COMMON SHARES
Basic Shares Outstanding	56.53M shares	56.52M shares	52.00M shares
Diluted Shares Outstanding	56.53M shares		52.00M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$35.97K	$52.21K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses	$61.35K	$16.72K
Receivables
Other Receivables
Total Short-Term Assets	$103.3K	$74.94K
YoY Change	-36.47%	-88.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$410.00	$695.00
YoY Change	-99.99%	-99.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$21.64K	$37.32K
YoY Change	-99.72%	-99.46%
TOTAL ASSETS
Total Short-Term Assets	$103.3K	$74.94K
Total Long-Term Assets	$21.64K	$37.32K
Total Assets	$125.0K	$112.3K
YoY Change	-98.41%	-98.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.095M	$5.758M
YoY Change	152.03%	256.09%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.095M	$5.758M
Total Long-Term Liabilities
Total Liabilities	$6.222M	$5.883M
YoY Change	51.2%	74.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$140.1M	-$138.9M
YoY Change	9.47%	9.19%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.135M	-$5.809M
YoY Change
Total Liabilities & Shareholders Equity	$125.0K	$112.3K
YoY Change	-98.41%	-98.52%

Cashflow Statement

Concept	2024 Q3	2024
OPERATING ACTIVITIES
Net Income	-$1.172M	-$11.69M
YoY Change	57.15%	266.59%
Depreciation, Depletion And Amortization	$285.00	$1.582K
YoY Change	-38.18%	-3.83%
Cash From Operating Activities	-$217.8K	-$849.2K
YoY Change	-44.92%	-71.0%
INVESTING ACTIVITIES
Capital Expenditures		$869.4K
YoY Change		-75.56%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$868.4K
YoY Change		-75.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$201.6K	$1.144M
YoY Change	171.5%	-71.05%
NET CHANGE
Cash From Operating Activities	-$217.8K	-$849.2K
Cash From Investing Activities		-$868.4K
Cash From Financing Activities	$201.6K	$1.144M
Net Change In Cash	-$16.24K	-$573.8K
YoY Change	-96.66%	-77.36%
FREE CASH FLOW
Cash From Operating Activities	-$217.8K	-$849.2K
Capital Expenditures		$869.4K
Free Cash Flow	-$217.8K	-$1.719M
YoY Change	-61.1%	-73.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	5836	usd
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
CY2024	bnet	Warrants Exercised Under Cashless Exercise WarrantsExercisedUnderCashlessExercise		usd
CY2024	bnet	Options Exercised Under Cashless Exercise OptionsExercisedUnderCashlessExercise		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-19333
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Public Float EntityPublicFloat	21500000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56532170	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	dei	Auditor Name AuditorName	Haynie & Company
CY2024	dei	Auditor Firm AuditorFirmId	457
CY2024	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52212	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16723	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16785	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	74935	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	648749	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36622	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	93875	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	695	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6851009	usd
CY2024Q2	us-gaap	Assets Assets	112252	usd
CY2023Q2	us-gaap	Assets Assets	7593633	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2703651	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	677136	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	890223	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	864781	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1708649	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2024Q2	bnet	Convertible Bridge Note Payable Current ConvertibleBridgeNotePayableCurrent	418659	usd
CY2023Q2	bnet	Convertible Bridge Note Payable Current ConvertibleBridgeNotePayableCurrent	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36431	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	75000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5757613	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1616917	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29068	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	125567	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2024Q2	bnet	Convertible Notes Payable Affiliates ConvertibleNotesPayableAffiliates	0	usd
CY2023Q2	bnet	Convertible Notes Payable Affiliates ConvertibleNotesPayableAffiliates	1715970	usd
CY2024Q2	us-gaap	Liabilities Liabilities	5883180	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3361955	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57227248	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48044790	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56522939	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47340480	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	133623927	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	131935418	usd
CY2024Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2023Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138927778	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127236663	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-5808501	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4194105	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5770928	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4231678	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112252	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7593633	usd
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2045849	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3072163	usd
CY2024	us-gaap	Depreciation Depreciation	1582	usd
CY2023	us-gaap	Depreciation Depreciation	1645	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23416	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	82759	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	2070847	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3156567	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2070847	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3156567	usd
CY2024	us-gaap	Interest Income Operating InterestIncomeOperating	652	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	972	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	159523	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	38384	usd
CY2024	bnet	Loss On Asset Impairment LossOnAssetImpairment	9460425	usd
CY2023	bnet	Loss On Asset Impairment LossOnAssetImpairment	0	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9620268	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-32548	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-11691115	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3189115	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-0	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-0	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11691115	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3189115	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51995654	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51995654	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45038479	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45038479	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2023	bnet	Sale Of Units Value SaleOfUnitsValue	1906230	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000	usd
CY2023	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	131335	usd
CY2023	bnet	Issuance Of Units For Services IssuanceOfUnitsForServices	130000	usd
CY2023	bnet	Issuance Of Warrant For Services Value IssuanceOfWarrantForServicesValue	62563	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	186462	usd
CY2023	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	249744	usd
CY2023	bnet	Stock Issued During Period Value Commission On Sale Of Units StockIssuedDuringPeriodValueCommissionOnSaleOfUnits	-86400	usd
CY2023	bnet	Modification Of Warrants Noncash Comp ModificationOfWarrantsNoncashComp	154932	usd
CY2023	bnet	Modification Of Warrants Interest ModificationOfWarrantsInterest	72589	usd
CY2023	bnet	Debt Modification Value DebtModificationValue	3507917	usd
CY2024	bnet	Sale Of Units Value SaleOfUnitsValue	610742	usd
CY2024	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	28500	usd
CY2024	bnet	Issuance Of Units For Services IssuanceOfUnitsForServices	112321	usd
CY2024	bnet	Issuance Of Warrant For Services Value IssuanceOfWarrantForServicesValue	5000	usd
CY2024	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	-18315	usd
CY2024	bnet	Vesting Of Warrants For Employees And Services VestingOfWarrantsForEmployeesAndServices	-13012	usd
CY2024	bnet	Debt Modification Value DebtModificationValue	-33720	usd
CY2024	bnet	Giveback Of Convertible Liabilities And Debt From Affiliates GivebackOfConvertibleLiabilitiesAndDebtFromAffiliates	726236	usd
CY2024	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	140951	usd
CY2024	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	150206	usd
CY2024	bnet	Stock Issued During Period Value Commission On Sale Of Units StockIssuedDuringPeriodValueCommissionOnSaleOfUnits	-20400	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-11691115	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5770928	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-11691115	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3189115	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1582	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1645	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense	159523	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	38384	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	-16325	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	249744	usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	112321	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	130000	usd
CY2024	bnet	Modification Of Warrants ModificationOfWarrants	0	usd
CY2023	bnet	Modification Of Warrants ModificationOfWarrants	154932	usd
CY2024	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	5000	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	62563	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-62	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-140765	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-0	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	345410	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-879618	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10384	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	27116	usd
CY2024	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	784332	usd
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	340000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-849169	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2928584	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	869398	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3557059	usd
CY2024	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	973	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-868425	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3557059	usd
CY2024	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	610742	usd
CY2023	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	3906230	usd
CY2024	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	131335	usd
CY2024	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	20400	usd
CY2023	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	86400	usd
CY2024	bnet	Proceeds From Convertible Bridge Loan ProceedsFromConvertibleBridgeLoan	400000	usd
CY2023	bnet	Proceeds From Convertible Bridge Loan ProceedsFromConvertibleBridgeLoan	0	usd
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	125000	usd
CY2024	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	28500	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1143842	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3951165	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-573752	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2534478	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52212	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024	bnet	Adjustment For Debt Modification AdjustmentForDebtModification	0	usd
CY2023	bnet	Adjustment For Debt Modification AdjustmentForDebtModification	3507917	usd
CY2024	bnet	Adjustment For Debt Modification From Giveback Agreements AdjustmentForDebtModificationFromGivebackAgreements	17734	usd
CY2023	bnet	Adjustment For Debt Modification From Giveback Agreements AdjustmentForDebtModificationFromGivebackAgreements	0	usd
CY2024	bnet	Adjustment For Deferred Compensationmodification From Giveback Agreements AdjustmentForDeferredCompensationmodificationFromGivebackAgreements	708502	usd
CY2023	bnet	Adjustment For Deferred Compensationmodification From Giveback Agreements AdjustmentForDeferredCompensationmodificationFromGivebackAgreements	0	usd
CY2024	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	140951	usd
CY2023	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	186462	usd
CY2024	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	0	usd
CY2023	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	23943	usd
CY2024	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	80767	usd
CY2023	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	90000	usd
CY2024	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	62163	usd
CY2023	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	179984	usd
CY2024	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	1681105	usd
CY2023	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	220052	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Stockholders Equity Other StockholdersEquityOther	5808501	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11691115	usd
CY2024Q2	bnet	Liability Current LiabilityCurrent	5800000	usd
CY2023Q2	bnet	Liability Current LiabilityCurrent	1600000	usd
CY2024	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	4200000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zWhYmh3GtaHW" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_861_zWuH8PRQ0L8u">Concentrations of credit risk</span>:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	48880237	shares
CY2023	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43758820	shares
CY2024	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2024	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	48175928	shares
CY2023	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43054511	shares
CY2024	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	3819726	shares
CY2023	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	1983968	shares
CY2024	bnet	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	51995654	shares
CY2023	bnet	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	45038479	shares
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zp5CenmO4Ht_zXGGwu0YTBPO" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_860_zgxJXfBRXP2c">Use of estimates</span>:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12607	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6862916	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11912	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11907	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	695	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6851009	usd
CY2024	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	74144	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	211984	usd
CY2024	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2023	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2024Q2	bnet	Carrying Value Of Initial Project CarryingValueOfInitialProject	0	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Depreciation Depreciation	1582	usd
CY2023	us-gaap	Depreciation Depreciation	1645	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	890223	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	864781	usd
CY2024Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2024	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	62162	usd
CY2023	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	179981	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q4	bnet	Initial Tranche InitialTranche	250000	usd
CY2024Q2	bnet	Carrying Value Of Initial Project CarryingValueOfInitialProject	0	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Stockholders Equity Other StockholdersEquityOther	5808501	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11691115	usd
CY2024	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2024	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	38000	shares
CY2024	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	38000	shares
CY2024	bnet	Total Proceeds TotalProceeds	28500	usd
CY2024Q2	bnet	Exercise Bonus ExerciseBonus	0.75	pure
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17100000	shares
CY2023Q3	bnet	Sale Of Warrants SaleOfWarrants	1003590	shares
CY2023Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1.25
CY2023Q3	bnet	Shares Issued Previously SharesIssuedPreviously	501795	shares
CY2023Q3	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2023-10-01
CY2024	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	38000	shares
CY2024	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	38000	shares
CY2024	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	28500	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4429263	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	805000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12006600	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.85
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M29D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5085659	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6950000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	50000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5001600	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2730	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	249744	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	83275	usd
CY2023Q2	bnet	Aggregate Payment AggregatePayment	2615500	usd
CY2023Q3	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	50000	usd
CY2024Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	16666	usd
CY2023Q3	bnet	Final Invoice Balance FinalInvoiceBalance	33334	usd
CY2024	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	6794925	usd
CY2024	bnet	Interest Costs Capitalized Paid InterestCostsCapitalizedPaid	7369529	usd
CY2024	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1681105	usd
CY2024	bnet	Interests Costs Incurred Capitalized InterestsCostsIncurredCapitalized	8406434	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Stockholders Equity Other StockholdersEquityOther	5808501	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-11691115	usd
CY2024Q2	bnet	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears	56250	usd
CY2024Q2	bnet	Undiscounted Cash Flow UndiscountedCashFlow	56250	usd
CY2024Q2	bnet	Less Imputed Interest LessImputedInterest	-2274	usd
CY2024Q2	bnet	Capital Lease Contingent Rental Payments Due CapitalLeaseContingentRentalPaymentsDue	53976	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	50000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2455000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-670000	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-428000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-117000	usd
CY2024	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	4000	usd
CY2023	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	9000	usd
CY2024	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	371000	usd
CY2023	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	733000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2508000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-45000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	42551000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8936000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8299000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5451000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5459000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3673000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000	usd
CY2024Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	377000	usd
CY2023Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	338000	usd
CY2024Q2	bnet	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployee	-641000	usd
CY2023Q2	bnet	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployee	1054000	usd
CY2024Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	49000	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	66000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17845000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16556000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17845000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16556000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure

Files In Submission

Name	View Source	Status
0001553350-24-000141-index-headers.html	Edgar Link	pending
0001553350-24-000141-index.html	Edgar Link	pending
0001553350-24-000141.txt	Edgar Link	pending
0001553350-24-000141-xbrl.zip	Edgar Link	pending
bion_10k-063024.htm	Edgar Link	pending
bion_ex31x1.htm	Edgar Link	pending
bion_ex31x2.htm	Edgar Link	pending
bion_ex32x1.htm	Edgar Link	pending
bion_ex32x2.htm	Edgar Link	pending
bnet-20240630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
bion_10k-063024_htm.xml	Edgar Link	completed
bnet-20240630_cal.xml	Edgar Link	unprocessable
bnet-20240630_def.xml	Edgar Link	unprocessable
bnet-20240630_pre.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bnet-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2024 Q3 Form 10-K Financial Statement

#000155335024000141 Filed on September 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2024 Q3 Form 10-K Financial Statement

#000155335024000141 Filed on September 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet